Literature DB >> 33272123

Cerebral Venous Thrombosis: Finnish Nationwide Trends.

Jori O Ruuskanen1, Ville Kytö2,3,4, Jussi P Posti5, Päivi Rautava6,7, Jussi O T Sipilä1,8.   

Abstract

BACKGROUND AND
PURPOSE: Epidemiology of cerebral venous thrombosis (CVT) has been reported to be changing. Because long-term nationwide data are needed to confirm this, we studied CVT occurrence between 2005 and 2014 in Finland.
METHODS: All acute CVT admissions were retrieved from a mandatory registry covering mainland Finland. Patients aged ≥18 years were included. One admission per patient was allowed.
RESULTS: We identified 563 patients with CVT (56.5% women). Overall incidence was 1.32/100 000 (95% CI, 1.21-1.43) per year with a 5.0% annual increase. In people <55 years of age, incidence was 0.92/100 000 (0.76-1.10) for men and 1.65/100 000 (1.43-1.89) for women, whereas for those 55 years or older incidence was 1.61 (1.34-1.91) for men and 1.17 (0.96-1.41) for women. In-hospital mortality was 2.1% with no sex difference. One-year mortality was 7.9%. Long-term mortality was higher in men (adjusted hazard ratio, 1.61 [1.09-2.38]) and in older patients (1.95 [1.69-2.24]; per 10-year increment).
CONCLUSIONS: Overall incidence of CVT in Finland was similar to that reported in the Netherlands and in Australia. There was a 5.0% yearly increase in the rate of admissions while in-hospital mortality was low. Sex-specific incidence rates differed markedly between younger and older people. Long-term mortality increased with age and was higher in men.

Entities:  

Keywords:  epidemiology; incidence; mortality; risk; thrombosis

Mesh:

Year:  2020        PMID: 33272123     DOI: 10.1161/STROKEAHA.120.031026

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

Review 1.  Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach.

Authors:  Malin Woock; Nicolas Martinez-Majander; David J Seiffge; Henriette Aurora Selvik; Annika Nordanstig; Petra Redfors; Erik Lindgren; Mayte Sanchez van Kammen; Alexandros Rentzos; Jonathan M Coutinho; Karen Doyle; Halvor Naess; Jukka Putaala; Katarina Jood; Turgut Tatlisumak
Journal:  Ther Adv Neurol Disord       Date:  2022-06-28       Impact factor: 6.430

Review 2.  Updates in Cerebral Venous Thrombosis.

Authors:  Arshia Alimohammadi; Diana J Kim; Thalia S Field
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

3.  Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study.

Authors:  Sharifa Nasreen; Andrew J Calzavara; Maria E Sundaram; Shannon E MacDonald; Christiaan H Righolt; Menaka Pai; Thalia S Field; Lily W Zhou; Sarah E Wilson; Jeffrey C Kwong
Journal:  BMJ Open       Date:  2021-12-17       Impact factor: 2.692

Review 4.  Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.

Authors:  Matthias Wittstock; Uwe Walter; Erik Volmer; Alexander Storch; Marc-André Weber; Annette Großmann
Journal:  Neuroradiology       Date:  2022-02-19       Impact factor: 2.804

5.  Cancer Occurrence After a Cerebral Venous Thrombosis: A Nationwide Registry Study.

Authors:  Jussi O T Sipilä; Jori O Ruuskanen; Eetu Heervä; Jussi P Posti; Päivi Rautava; Ville Kytö
Journal:  Stroke       Date:  2022-04-05       Impact factor: 7.914

6.  An unusual clinical manifestation of coronavirus disease 2019 in a woman with twin pregnancy: a case report.

Authors:  Laleh Eslamian; Seyedeh Noushin Ghalandarpoor-Attar; Azadeh Shabani; Seyedeh Mojgan Ghalandarpoor-Attar
Journal:  J Med Case Rep       Date:  2022-04-19

Review 7.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

8.  Gender Differences in Risk Factor Profile and Clinical Characteristics in 89 Consecutive Cases of Cerebral Venous Thrombosis.

Authors:  Zoltan Bajko; Anca Motataianu; Adina Stoian; Laura Barcutean; Sebastian Andone; Smaranda Maier; Iulia-Adela Drăghici; Andrada Cioban; Rodica Balasa
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

9.  Postpartum Cerebral Venous Thrombosis-A Single-Center Experience.

Authors:  Zoltan Bajko; Anca Motataianu; Adina Stoian; Laura Barcutean; Sebastian Andone; Smaranda Maier; Iulia-Adela Drăghici; Rodica Balasa
Journal:  Brain Sci       Date:  2021-03-04

10.  COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.

Authors:  Jörg B Schulz; Peter Berlit; Hans-Christoph Diener; Christian Gerloff; Andreas Greinacher; Christine Klein; Gabor C Petzold; Marco Piccininni; Sven Poli; Rainer Röhrig; Helmuth Steinmetz; Thomas Thiele; Tobias Kurth
Journal:  Ann Neurol       Date:  2021-08-23       Impact factor: 11.274

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.